19.9.2018 Update from the European Medicines Agency on the risk assessment of impurity-containing valsartan medicines

18.9.2018 Fimea’s administrative regulation ‘Applying for and maintaining a marketing authorisation and registration for a medicinal product’ has been updated

10.9.2018 When food supplements purchased from distant lands contains designer drugs or a charger burns down the house, the buyer is responsible

4.9.2018 Research network provides added effectiveness, multidisciplinarity and competence to pharmacotherapies

29.8.2018 Text ‘Itsehoitolääke / Receptfritt läkemedel’ to be added on over-the-counter medicine packages

9.8.2018 Rational pharmacotherapy research seminar, 21 August - register by 10th August

9.8.2018 EMA conducted a preliminary assessment of the effect of impurities in medicines containing valsartan on human health

10.7.2018 Blood pressure medicines withdrawn from the market due to quality problems

27.6.2018 Eija Pelkonen appointed as Fimea’s Director-General

19.6.2018 European HTA community and pharmaceutical industry gathered in Stockholm